Unknown

Dataset Information

0

A call to caution when hydroxychloroquine is given to elderly patients with COVID-19.


ABSTRACT:

Introduction

Use of hydroxychloroquine in patients with coronavirus disease 2019 (COVID-19) was widespread and uncontrolled until recently. Patients vulnerable to severe COVID-19 are at risk of hydroxychloroquine interactions with co-morbidities and co-medications contributing to detrimental, including fatal, adverse treatment effects.

Methods

A retrospective survey was undertaken of health conditions and co-medications of patients with COVID-19 who were pre-screened for enrolment in a randomized, double-blind, placebo-controlled hydroxychloroquine multi-centre trial.

Results

The survey involved 305 patients [median age 71 (interquartile range 59-81) years]. The majority of patients (n = 279, 92%) considered for inclusion in the clinical trial were not eligible, mainly due to safety concerns caused by health conditions or co-medications. The most common were QT-prolonging drugs (n = 188, 62%) and haematologic/haemato-oncologic diseases (n = 39, 13%) which prohibited the administration of hydroxychloroquine. In addition, 165 (54%) patients had health conditions and 167 (55%) patients were on co-medications that did not prohibit the use of hydroxychloroquine but had a risk of adverse interactions with hydroxychloroquine. The most common were diabetes (n = 86, 28%), renal insufficiency (n = 69, 23%) and heart failure (n = 58, 19%).

Conclusion

The majority of hospitalized patients with COVID-19 had health conditions or took co-medications precluding safe treatment with hydroxychloroquine. Therefore, hydroxychloroquine should be administered with extreme caution in elderly patients with COVID-19, and only in clinical trials.

SUBMITTER: Gabor JJ 

PROVIDER: S-EPMC8035801 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2021-03-09 | GSE164332 | GEO
| S-EPMC9347612 | biostudies-literature
| S-EPMC8409974 | biostudies-literature
| S-EPMC7354765 | biostudies-literature
| S-EPMC7556338 | biostudies-literature
| S-EPMC8237004 | biostudies-literature
| S-EPMC7698654 | biostudies-literature
| S-EPMC7224609 | biostudies-literature
| S-BSST416 | biostudies-other
| S-EPMC7425928 | biostudies-literature